These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37816734)

  • 1. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
    Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
    Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth.
    Zhou T; Sang YH; Cai S; Xu C; Shi MH
    Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth.
    Wang H; Liu Y; Lu XS; Wu Y; Gu W; Yin G
    Cell Death Dis; 2024 Sep; 15(9):643. PubMed ID: 39227564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
    Li SP; Ou L; Zhang Y; Shen FR; Chen YG
    Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
    Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
    Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth.
    Wang Y; Ou L; Li X; Zheng T; Zhu WP; Li P; Wu L; Zhao T
    Cell Death Discov; 2022 Aug; 8(1):347. PubMed ID: 35922422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma.
    Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q
    Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the central role of RNA polymerase mitochondrial for angiogenesis.
    Huan MJ; Fu PP; Chen X; Wang ZX; Ma ZR; Cai SZ; Jiang Q; Wang Q
    Cell Commun Signal; 2024 Jun; 22(1):343. PubMed ID: 38907279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMM44 is a potential therapeutic target of human glioma.
    Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
    Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression.
    Yan W; Xie C; Sun S; Zheng Q; Wang J; Wang Z; Man CH; Wang H; Yang Y; Wang T; Shi L; Zhang S; Huang C; Xu S; Wang YP
    EMBO J; 2024 Jun; 43(12):2337-2367. PubMed ID: 38649537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
    Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
    Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
    Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
    Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo.
    Ma ZR; Li HP; Cai SZ; Du SY; Chen X; Yao J; Cao X; Zhen YF; Wang Q
    Cell Death Dis; 2023 May; 14(5):307. PubMed ID: 37147302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
    Mi YY; Ji Y; Zhang L; Sun CY; Wei BB; Yang DJ; Wan HY; Qi XW; Wu S; Zhu LJ
    Cell Death Dis; 2023 Jan; 14(1):67. PubMed ID: 36709328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
    Han Q; Yan P; Song R; Liu F; Tian Q
    Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
    Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
    Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADCK1 is a potential therapeutic target of osteosarcoma.
    Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
    Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression.
    Wang Z; Cotney J; Shadel GS
    J Biol Chem; 2007 Apr; 282(17):12610-8. PubMed ID: 17337445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.